Page last updated: 2024-10-30

lobenzarit and Alloxan Diabetes

lobenzarit has been researched along with Alloxan Diabetes in 2 studies

lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"Lobenzarit was given to 12 recipients and OK-432 to seven recipients intraperitoneally for 1 month, while nine controls received only intraperitoneal saline."1.28Lack of favorable effect of immunomodulators on outbred syngeneic rodent islet transplantation. ( Ejiri, K; Hara, Y; Ishida, Y; Ishihara, K; Kuroda, N; Morimoto, Y; Shin, SJ; Taniguchi, H; Tsai, JH; Yamashiro, Y, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shin, SJ1
Taniguchi, H1
Hara, Y1
Ejiri, K1
Morimoto, Y1
Yamashiro, Y1
Ishida, Y1
Kuroda, N1
Ishihara, K1
Tsai, JH1
Iwakiri, R1
Nagafuchi, S1

Other Studies

2 other studies available for lobenzarit and Alloxan Diabetes

ArticleYear
Lack of favorable effect of immunomodulators on outbred syngeneic rodent islet transplantation.
    Diabetes research and clinical practice, 1990, Volume: 8, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Biological Products; Blood Glucose; Diabetes Mellitus, Experimental

1990
Inhibition of streptozocin-induced insulitis and diabetes with lobenzarit in CD-1 mice.
    Diabetes, 1989, Volume: 38, Issue:5

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hyperglycemia; Islets of Langerhans; Male;

1989